MedPath

Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Not Applicable
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Patients Hospitalized for a COPD Exacerbation
Interventions
Other: PEP
Registration Number
NCT02035293
Lead Sponsor
University Hospital, Brest
Brief Summary

A standardized diagnostic strategy of pulmonary embolism will be applied to eligible patients, incorporating a clinical probability score (revised Geneva score), plasma D-dimer assay and if necessary, a multidetector-row CT angiography thoracic and venous ultrasound of the lower limbs. All the patient with a pulmonary embolism diagnosed or not, will be followed for 3 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
750
Inclusion Criteria
  • Patients hospitalized for a COPD exacerbation
  • COPD previously diagnosed
Exclusion Criteria
  • Allergy to iodinated contrast
  • Creatinine clearance < 30 mL / min
  • Patient hospitalized for exacerbation of COPD for more than 48 hours
  • Pneumothorax
  • Exams impossible to be performed
  • Pregnancy
  • Life expectancy < 3 months
  • Patients already receiving anticoagulant therapy for another reason (mechanical valve, cardiac arrhythmia).

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
PEPPEPNo drug and no placebo were used in this study. For all the patients who participated at the study PEP, only following exams must be performed: a clinical probability score (revised Geneva score), plasma D-dimer assay and if necessary, a chest multidetector-row CT angiography and venous ultrasound of the lower limbs
Primary Outcome Measures
NameTimeMethod
Frequency of pulmonary embolism in patients hospitalized for a clinical exacerbation of COPD.27 months
Secondary Outcome Measures
NameTimeMethod
The rate of pulmonary embolism diagnosed during the 3 month follow-up in patients whom pulmonary embolism was initially excluded when they've been included in the study27 months

Trial Locations

Locations (7)

CHU

🇫🇷

Angers, France

HIA

🇫🇷

Brest, France

CHRU de Brest

🇫🇷

Brest, France

CHU Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

CH de Cornouaille Quimper

🇫🇷

Quimper, France

Hôpital Nord

🇫🇷

St-Etienne, France

Hôpital Européen Georges Pompidou

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath